MedPath
NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

国药准字H20243794

May 21, 2024

Drug Information

盐酸莫西沙星滴眼液

眼用制剂

0.5%(5ml:25mg,按C₂₁H₂₄FN₃O₄计)

化学药品

May 21, 2024

Company Information

Applicant Company

广州市黄埔区开源大道11号A3栋301室

Manufacturing Company

广州市黄埔区瑞泰路7号自编一、二、三、五栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath